Soy food intake and breast cancer survival - PubMed (original) (raw)
Soy food intake and breast cancer survival
Xiao Ou Shu et al. JAMA. 2009.
Abstract
Context: Soy foods are rich in isoflavones, a major group of phytoestrogens that have been hypothesized to reduce the risk of breast cancer. However, the estrogen-like effect of isoflavones and the potential interaction between isoflavones and tamoxifen have led to concern about soy food consumption among breast cancer patients.
Objective: To evaluate the association of soy food intake after diagnosis of breast cancer with total mortality and cancer recurrence.
Design, setting, and participants: The Shanghai Breast Cancer Survival Study, a large, population-based cohort study of 5042 female breast cancer survivors in China. Women aged 20 to 75 years with diagnoses between March 2002 and April 2006 were recruited and followed up through June 2009. Information on cancer diagnosis and treatment, lifestyle exposures after cancer diagnosis, and disease progression was collected at approximately 6 months after cancer diagnosis and was reassessed at 3 follow-up interviews conducted at 18, 36, and 60 months after diagnosis. Annual record linkage with the Shanghai Vital Statistics Registry database was carried out to obtain survival information for participants who were lost to follow-up. Medical charts were reviewed to verify disease and treatment information.
Main outcome measures: Total mortality and breast cancer recurrence or breast cancer-related deaths. Cox regression analysis was carried out with adjustment for known clinical predictors and other lifestyle factors. Soy food intake was treated as a time-dependent variable.
Results: During the median follow-up of 3.9 years (range, 0.5-6.2 years), 444 deaths and 534 recurrences or breast cancer-related deaths were documented in 5033 surgically treated breast cancer patients. Soy food intake, as measured by either soy protein or soy isoflavone intake, was inversely associated with mortality and recurrence. The hazard ratio associated with the highest quartile of soy protein intake was 0.71 (95% confidence interval [CI], 0.54-0.92) for total mortality and 0.68 (95% CI, 0.54-0.87) for recurrence compared with the lowest quartile of intake. The multivariate-adjusted 4-year mortality rates were 10.3% and 7.4%, and the 4-year recurrence rates were 11.2% and 8.0%, respectively, for women in the lowest and highest quartiles of soy protein intake. The inverse association was evident among women with either estrogen receptor-positive or -negative breast cancer and was present in both users and nonusers of tamoxifen.
Conclusion: Among women with breast cancer, soy food consumption was significantly associated with decreased risk of death and recurrence.
Conflict of interest statement
Conflicts of Interest: XOS received a small research development fund from the United Soybean Board in 2005. The United Soybean Board played no role in the design, implementation, or result interpretation of this study or in the preparation or approval of the manuscript. No other authors have any conflicts of interest to declare.
Figures
Comment in
- Challenges in design and interpretation of observational research on health behaviors and cancer survival.
Ballard-Barbash R, Neuhouser ML. Ballard-Barbash R, et al. JAMA. 2009 Dec 9;302(22):2483-4. doi: 10.1001/jama.2009.1807. JAMA. 2009. PMID: 19996407 No abstract available.
Similar articles
- Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ. Guha N, et al. Breast Cancer Res Treat. 2009 Nov;118(2):395-405. doi: 10.1007/s10549-009-0321-5. Epub 2009 Feb 17. Breast Cancer Res Treat. 2009. PMID: 19221874 Free PMC article. - Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.
Kang X, Zhang Q, Wang S, Huang X, Jin S. Kang X, et al. CMAJ. 2010 Nov 23;182(17):1857-62. doi: 10.1503/cmaj.091298. Epub 2010 Oct 18. CMAJ. 2010. PMID: 20956506 Free PMC article. - Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
Zhang FF, Haslam DE, Terry MB, Knight JA, Andrulis IL, Daly MB, Buys SS, John EM. Zhang FF, et al. Cancer. 2017 Jun 1;123(11):2070-2079. doi: 10.1002/cncr.30615. Epub 2017 Mar 6. Cancer. 2017. PMID: 28263368 Free PMC article. - Soy for breast cancer survivors: a critical review of the literature.
Messina MJ, Loprinzi CL. Messina MJ, et al. J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. doi: 10.1093/jn/131.11.3095S. J Nutr. 2001. PMID: 11694655 Review. - Soy, red clover, and isoflavones and breast cancer: a systematic review.
Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Kennedy D, Cooley K, Wong R, Sagar S, Sabri E, Fergusson D. Fritz H, et al. PLoS One. 2013 Nov 28;8(11):e81968. doi: 10.1371/journal.pone.0081968. eCollection 2013. PLoS One. 2013. PMID: 24312387 Free PMC article. Review.
Cited by
- Integrative Geriatric Oncology: A Review of Current Practices.
Fine H, Bonthu A, Kogan M. Fine H, et al. Curr Oncol Rep. 2024 Oct;26(10):1146-1158. doi: 10.1007/s11912-024-01575-w. Epub 2024 Jul 23. Curr Oncol Rep. 2024. PMID: 39042197 Review. - Anti-cancer mechanisms of natural isoflavones against melanoma.
Liang C, Wang P, Li M, Li R, Lai KP, Chen J. Liang C, et al. Heliyon. 2024 Mar 27;10(7):e28616. doi: 10.1016/j.heliyon.2024.e28616. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38586368 Free PMC article. Review. - Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness.
Carrano R, Grande M, Leti Maggio E, Zucca C, Bei R, Palumbo C, Focaccetti C, Nardozi D, Lucarini V, Angiolini V, Mancini P, Barberini F, Barillari G, Cifaldi L, Masuelli L, Benvenuto M, Bei R. Carrano R, et al. Biomedicines. 2024 Feb 21;12(3):482. doi: 10.3390/biomedicines12030482. Biomedicines. 2024. PMID: 38540096 Free PMC article. Review. - The Importance of Nutrition in Menopause and Perimenopause-A Review.
Erdélyi A, Pálfi E, Tűű L, Nas K, Szűcs Z, Török M, Jakab A, Várbíró S. Erdélyi A, et al. Nutrients. 2023 Dec 21;16(1):27. doi: 10.3390/nu16010027. Nutrients. 2023. PMID: 38201856 Free PMC article. Review. - Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
Anuranjana PV, Beegum F, K P D, George KT, Viswanatha GL, Nayak PG, Kanwal A, Kishore A, Shenoy RR, Nandakumar K. Anuranjana PV, et al. F1000Res. 2023 Dec 11;12:107. doi: 10.12688/f1000research.126059.3. eCollection 2023. F1000Res. 2023. PMID: 38106650 Free PMC article. Review.
References
- Mouridsen HT, Rose C, Brodie AH, Smith IE. Challenges in the endocrine management of breast cancer. Breast. 2003;12 2:S2–19. - PubMed
- Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997;29(2):95–120. - PubMed
- Taylor CK, Levy RM, Elliott JC, Burnett BP. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev. 2009;67(7):398–415. - PubMed
- Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98(7):459–471. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous